Department of Biosciences, Integral University, Lucknow, India.
Department of Biosciences, Integral University, Lucknow, India.
Tuberculosis (Edinb). 2023 Dec;143:102395. doi: 10.1016/j.tube.2023.102395. Epub 2023 Aug 17.
The advent of effective drug regimen and BCG vaccine has significantly decreased the rate of morbidity and mortality of TB. However, lengthy treatment and slower recovery rate, as well as reactivation of the disease with the emergence of multi-drug, extensively-drug, and totally-drug resistance strains, pose a serious concern. The complexities associated are due to the highly evolved and complex nature of the bacterium itself. One of the unique features of Mycobacterium tuberculosis [M.tb] is that it has undergone reductive evolution while maintaining and amplified a few gene families. One of the critical gene family involved in the virulence and pathogenesis is the Toxin-Antitoxin system. These families are believed to harbor virulence signature and are strongly associated with various stress adaptations and pathogenesis. The M.tb TA systems are linked with growth regulation machinery during various environmental stresses. The genes of TA systems are differentially expressed in the host during an active infection, oxidative stress, low pH stress, and starvation, which essentially indicate their role beyond growth regulators. Here in this review, we have discussed different roles of TA gene families in various stresses and their prospective role at the host-pathogen interface, which could be exploited to understand the M.tb associated pathomechanisms better and further designing the new strategies against the pathogen.
有效的药物治疗方案和卡介苗疫苗的出现显著降低了结核病的发病率和死亡率。然而,治疗时间长、恢复速度慢,以及多药、广泛耐药和完全耐药菌株的出现导致疾病复发,这令人严重关切。这些复杂性源于细菌本身高度进化和复杂的性质。结核分枝杆菌[M.tb]的一个独特特征是,它在维持和扩增少数基因家族的同时经历了还原进化。与毒力和发病机制相关的一个关键基因家族是毒素-抗毒素系统。这些家族被认为蕴藏着毒力特征,与各种应激适应和发病机制密切相关。M.tb 的 TA 系统与各种环境应激下的生长调控机制有关。在宿主的活性感染、氧化应激、低 pH 应激和饥饿期间,TA 系统的基因差异表达,这实质上表明它们的作用超出了生长调节剂。在这篇综述中,我们讨论了 TA 基因家族在各种应激中的不同作用及其在宿主-病原体界面的潜在作用,这可以帮助我们更好地理解与 M.tb 相关的病理机制,并进一步设计针对病原体的新策略。